Monday 20 July 2020

Coronavirus LIVE Updates: Serum Institute of India eyes licence to manufacture Oxford vaccine after positive result in early trial

09:16 (IST)

Coronavirus Outbreak in India Latest Updates

India reports over 37,000 new cases, 587 deaths in past 24 hrs

India reports 37,148 new cases, taking the its total count to 11,55,191. The toll rises by 587 to 28,084. Total active cases are now more than 4 lakh.

09:05 (IST)

Coronavirus Outbreak Latest Updates

Over a million doses of Oxford COVID-19 vaccine possible by September: Researcher

Early estimates of the production a million doses of the University of Oxford's experimental COVID-19 vaccine by September could be an underestimate depending on how quickly late-stage trials can be completed, a researcher said on Monday, reports Reuters.

"There might be a million doses manufactured by September: that now seems like a remarkable underestimate, given the scale of what's going on," Adrian Hill of University of Oxford said, referring to the manufacturing capability of partner AstraZeneca.

08:52 (IST)

Coronavirus Outbreak in Sikkim Latest Updates

Sikkim to remain under complete lockdown till 27 July

The Sikkim government yesterday announced imposition of a complete lockdown in the state from today till 27 July in view of the recent surge in COVID-19 cases.

Government offices, shops, commercial establishments, institutions, markets and factories will remain closed except where a specific exemption is granted, according to a notification.

08:36 (IST)

Coronavirus Outbreak in India Latest Updates

Serum to apply for local trials on Oxford's vaccine in a week

With the trials of COVID-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, Serum Institute of India (SII) on Monday said it will apply for licence from the Indian regulator to start clinical trials of the shot in a week's time.

"The trials have shown promising results and we are extremely happy about it. We will be applying for the licensure trials to the Indian regulator in a week's time. As soon as they grant us permission, we will begin with the trials for the vaccine in India. In addition, we will soon start manufacturing the vaccine in large volumes," SII Chief Executive Officer Adar Poonawalla said.

08:03 (IST)

Coronavirus Outbreak in India Latest Updates

Clinical trials of Covaxin to start at Bhubaneswar from tomorrow

Human clinical trials of the country's indigenously developed Covid-19 vaccine is set to begin this week at a Bhubaneswar-based institute – one of the 12 centres selected by the ICMR for conducting phase one and two of the process, a senior official said.

The human trials of BBV152 Covid Vaccine or Covaxin will begin on Wednesday in a special laboratory set up at the Institute of Medical Sciences and SUM (IMS & SUM) Hospital, in accordance with the protocols laid down by the Drugs Controller General of India (DCGI), reports PTI.

07:54 (IST)

Coronavirus Outbreak in India Latest Updates

Indian medical experts hail Oxford trial results for Covid-19 vaccine

Medical experts in India on Monday hailed the results of Oxford University's early-stage human trials for a Covid-19 vaccine, with some saying it's the "most scientifically done" among all such exercises, while others expressing hope that the final trials will "bear fruit".

From clinicians to pathology experts, doctors in the country feel the Oxford trials have been the "most transparent" one by far.

07:52 (IST)

Coronavirus Outbreak in India Latest Updates

ICMR, Union health ministry advise states on how to enhance testing capacity

The ICMR and the Union health ministry have suggested short and medium term methods to all states and union territories for enhancing their COVID-19 testing capacity.

In a joint letter issued on 17 July, Union health ministry secretary Preeti Sudan and Indian Council of Medical Research (ICMR) Director General Balram Bhargava said the evolving scenario demands for enhanced testing capabilities to handle any surge in testing demands.

Increasing the testing capacity may be achieved by adding more laboratories for COVID-19 testing and enhancing the existing testing capacity of the approved laboratories, the letter said.

07:49 (IST)

Coronavirus Outbreak in Delhi Latest Updates

Hindu Rao hospital nurse tests 'positive' again, NDMC says nothing to worry

A nurse employed at a civic-run dedicated COVID-19 hospital has tested positive again after recovering, but the municipal authorities on Monday claimed there was nothing to worry as it ostensibly is the "dead virus" left in her body from the previous infection.

The hospital, run by the North Delhi Municipal Corporation (NDMC), was declared a dedicated coronavirus facility on 14 June.

07:47 (IST)

Coronavirus Outbreak in India Latest Updates

Serum Institute of India eyes licence to manufacture Oxford vaccine

The Serum Institute of India says it will seeking to get the licence to manufacture the vaccine developed at the Oxford University, reports NDTV. Trials will begin in India as soon as the license is procured. The vaccine has been found to be both effective and safe in early trials, according to a study in the medical journal The Lancet.

07:44 (IST)

Coronavirus Outbreak in Assam Latest Updates

Assam records 1,093 new cases; infection total crosses 25,000-mark

Assam breached the 25,000-mark in COVID-19 cases with 1,093 fresh cases reported on Monday, while one more person died due to the disease in the state, Health Minister Himanta Biswa Sarma said.

The state, at present, has 7,936 active coronavirus patients, who are being treated in different hospitals and COVID care centres, he said on Twitter.

07:35 (IST)

Coronavirus Outbreak in Goa Latest Updates

Human trials of Covaxin begin at Goa's Redkar Hospital: Pramod Sawant

Goa Chief Minister Pramod Sawant has said that the human trials of coronavirus vaccine have begun at the state's Redkar Hospital and congratulated the team behind it.

The country's top drug regulator had recently given a green signal for human clinical trials for COVID-19 vaccine candidate Covaxin, which has been developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology

Coronavirus LATEST Updates: The Serum Institute of India says it will seeking to get the licence to manufacture the vaccine developed at the Oxford University, reports NDTV. The vaccine has been found to be both effective and safe in early trials, according to a study in the medical journal The Lancet.

The total number of coronavirus cases crossed 11 lakh with a single-day spike of 40,425 cases on Monday, while the toll rose to 27,497 with 681 new casualties reported. It is the first time the number of new cases registered was above 40,000.

The total tally of 11,18,043 cases includes 3,90,459 active cases and 7,00,087 cured/discharged/migrated patients and the toll.  The health ministry said that the recovery rate is now 62.62 percent.

Meanwhile, a vaccine candidate developed at the University of Oxford has shown encouraging results in early human testing and appears to be "safe well-tolerated, and immunogenic", according to a study published in The Lancet on Monday.

Oxford's COVID-19 vaccine produces 'strong antibodies', shows initial study

Trials by the Oxford University involving 1,077 people showed that the injection led to them making antibodies and white blood cells that can fight coronavirus. The vaccine, named 'ChAdOx1 nCoV-19', has been made from a harmless virus called 'chimpanzee cold virus'.

"Our preliminary findings show that the candidate ChAdOx1 nCoV-19 vaccine given as a single dose was safe and tolerated, despite a higher reactogenicity profile than the control vaccine, MenACWY," the researchers, led by Pedro M Folegatti and Katiet Ewer, wrote in the study.

"No serious adverse reactions to ChAdOx1 nCoV-19 occurred. The majority of adverse events reported were mild or moderate in severity, and all were self-limiting," the study said.

The clinical trials of a potential COVID-19 vaccine on humans began in April. The human vaccine trial has been developed by scientists at Oxford University's Jenner Institute.

Reportedly, the scientists also said that they "found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55 that lasted at least two months after they were immunised".

The study showed that the vaccine induced strong antibody and T-cell immune responses up to day 56 of the ongoing trial.

“We are seeing good immune response in almost everybody,” said Dr Adrian Hill, director of the Jenner Institute at Oxford University. “What this vaccine does particularly well is trigger both arms of the immune system,” he said.

ICC postpones Men's T20 World Cup due to COVID-19 pandemic

The International Cricket Council (ICC) announced the postponement of this year's Men's T20World Cup in Australia due to the ongoing coronavirus pandemic. The T20 World Cup was slated to be played in Australia from 18 October to 15 November this year.

"The IBC Board (the commercial subsidiary of the ICC) agreed to continue to monitor the rapidly changing situation (regarding coronavirus pandemic) and assess all the information available in order to make a considered decision on future hosts to ensure the sport is able to stage safe and successful global events in 2021 and 2022," ICC said in a statement.

"The IBC Board will also continue to evaluate the situation in relation to being able to stage the ICC Women's Cricket World Cup 2021 in New Zealand in February next year. In the meantime, planning for this event continues as scheduled," the statement added.

ICC Chief Executive Manu Sawhney said their number one priority was to protect the health and safety of everyone involved in the sport.

Delhi seems to have reached COVID-19 peak, says AIIMS chief

Certain areas of Delhi have hit their peak of the COVID-19 pandemic, while certain other areas in the city are yet to reach the peak, said AIIMS director Dr Randeep Guleria on Monday. He added that there is not much evidence of community transmission happening at the national level.

"Certain areas have hit their peak in COVID-19 cases. Delhi seems to have done so because the cases have declined significantly. Certain areas have yet to reach the peak. They will reach the peak a little later," Guleria said, while addressing a press conference.

The National Capital had witnessed a surge in the cases of novel coronavirus cases over the past one month. However, the number of active cases has seen a dip over the past few weeks.

Bengal govt to enforce lockdown for two days every week

In light of the rising number of COVID-19 cases in the state, the West Bengal government announced a lockdown in the state for two days every week starting from 23 July.

In a press meet, the West Bengal home secretary said, "There will be a two-day complete lockdown every week starting from Thursday. Lockdown will be on Thursday and Saturday this week. This lockdown has been imposed in addition to running a broad-based containment zone approach."

The two days of lockdown will be decided on a weekly basis.

"All views have been taken into account and it has been decided the days for the lockdown will be announced each week. There will be complete lockdown in offices and transport," the official added.

State-wise cases and deaths

Maharashtra reported 176 deaths and 8,240 new COVID-19 cases on Monday. The total count of cases now stands at 3,18,695, including 1,75,029 recovered cases and 1,31,334 active cases.

Meanwhile, Mumbai reported 1,043 new COVID-19 cases, 965 cured patients and 41 deaths. The total number of cases in the city stands at 1,02,267, including 23,865 active cases, 72,650 discharged patients and 5,752 deaths.

A total 4,985 COVID-19 cases and 70 deaths were reported in Tamil Nadu. The total number of cases has risen to 1,75,678, including 51,348 active cases and 2,551 deaths.

Delhi reported 954 new COVID-19 positive cases, 1,784 recovered /discharged/migrated patients and 35 deaths. The total count of cases has risen to 1,23,747 including 1,04,918 recovered/discharged/migrated and 3,663 deaths.

Karnataka reported 3,648 COVID-19 cases and 72 deaths, taking active cases to 42,216 and toll to 1,403. Kerala reported 794 COVID-19 cases on Monday, taking the number of active cases to 7,611. A total of 5,618 patients have been discharged so far in the state.

Punjab reported 411 new COVID-19 positive cases and eight deaths. The total number of cases has risen to 10,510, including 3,130 active cases, 7,118 discharged patients and 262 deaths.

Telangana recorded 1,198 new COVID-19 cases and seven deaths. The total count of cases has risen to 46,274, including 11,530 active cases and 422 deaths.

Uttar Pradesh reported 1,924 COVID-19 cases and 46 deaths in the last 24 hours. The active cases stand at 19,137 and the toll has risen to 1,192. A total of 30,831 patients have been discharged so far.

Rajasthan reported 956 new COVID-19 cases and nine deaths till 8.30 pm on Monday. The total number of cases has risen to 30,390, including 7,627 active cases and 568 patients have died due to the disease.

A total of 998 COVID-19 cases and 20 deaths were reported in the last 24 hours in Gujarat. The state's count of cases has risen to 49,439, including 11,613 active cases, 35,659 cured/discharged patients and 2,167 deaths.

Manipur's COVID-19 case count has risen to 1,925 with 14 new cases reported today. The number of recovered cases is 1,320 and there are 605 active cases.

With inputs from agencies



from Firstpost India Latest News https://ift.tt/2CzAXRD
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)